Literature DB >> 27346188

Spinning: an arising cause of rhabdomyolysis in young females.

Y H Kim1, Y R Ham1, K R Na1, K W Lee1, D E Choi2.   

Abstract

BACKGROUND: 'Spinning' is an indoor cycling regimen. The number of case reports of spinning-induced rhabdomyolysis (SIR) has increased since 2004 in South Korea. AIM: The aim of this study is to evaluate the clinical characteristics of SIR and compare it with other causes of rhabdomyolysis.
METHODS: Patients who were diagnosed with rhabdomyolysis from 1 September 2011 to 30 April 2015 were included. We analysed the incidence of rhabdomyolysis, biochemical parameters and forced hospitalisation, which was defined as the days from admission to creatinine phosphokinase < 2000 IU/L.
RESULTS: Among 70 included patients, 13 (18.6%) patients were diagnosed with SIR. The mean age of the patients with SIR was 25.69 ± 5.0 years, and most were females under 35 years old (12, 92.3%). Interestingly, the mean duration of spinning exercise before admission was only 59.23 min. Moreover, the patients with SIR showed more severe progress than the all-patients-except-SIR (AESIR) group. The serum creatinine phosphokinase, aspartate transaminase and alanine transaminase levels of the patients with SIR were statistically significantly higher than the patients with AESIR. Additionally, the duration of forced hospitalisation was longer than that of the AESIR (P < 0.01).
CONCLUSIONS: Spinning could be an important cause of rhabdomyolysis in young, unfit females, which is typically severe. A graded exercise programme is advised at the first session.
© 2016 Royal Australasian College of Physicians.

Entities:  

Keywords:  acute kidney injury; exercise; rhabdomyolysis

Mesh:

Substances:

Year:  2016        PMID: 27346188     DOI: 10.1111/imj.13168

Source DB:  PubMed          Journal:  Intern Med J        ISSN: 1444-0903            Impact factor:   2.048


  1 in total

1.  Case Report: Exertional rhabdomyolysis in a spin class participant with sickle cell trait.

Authors:  Teresa Longo; Matthew Shaines
Journal:  F1000Res       Date:  2018-11-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.